Who AI recommends, and when it changes.
Data as of Apr 9, 2026 · Based on 47 AI answers · A buyer need in Deep Tech Venture Capital Firms. · See how Parse measures this
Between March and April 2026, AI assistants split their top recommendations for patient deep tech capital between and , with both capturing an equal share of mentions. trailed closely as the third most-cited firm, reflecting a competitive landscape where no single fund dominates AI answers for this need.
Where a different pick wins:
EIC Accelerators offers a hybrid grant-equity model up to 17.5M euros, designed for long R&D timelines in Europe. · 1 source
SBIR provides non-dilutive grants for early-stage deep tech, often serving as 'America's Seed Fund'. · 1 source
Third Rock partners with scientific founders and supports extended clinical development, making it a go-to for biotech. · 2 sources
SOSV's IndieBio and HAX accelerators provide lab space and intensive support for hardware and life sciences startups. · 2 sources
Khosla Ventures is frequently recommended for high-risk sustainability and clean energy bets that demand patient capital. · 2 sources
Recommendation share
DCVC leads at 11% of AI recommendations; The Engine follows at 11%.
By platform
Platforms disagree: The Engine leads on Google AI Overviews, DCVC on ChatGPT.
Representative prompts behind this market ranking, and how AI tends to answer.
Buyer needs that sit next to this one in the same market.
Why here: Cited as a deep tech VC investing in hard science and computational problems with a long-term thesis. · 5 sources
Why here: Structured to support 'tough tech' startups with patient capital and lab facilities. · 5 sources
Why here: Known for high-risk bets on sustainability, synthetic biology, and AI before commercial traction. · 4 sources
Why here: Mission-driven firm funding global problem-solving through deep science with a patient approach. · 3 sources
Why here: Creates and incubates biotech companies internally, often for years before launch. · 3 sources
“I need to find investors for my deep tech startup with a long R&D timeline. Which funds are known for their "patient capital"?”
AI answered this with a wide list of deep tech VCs, but DCVC,
The Engine, and appeared most consistently as the top recommendations for patient long-horizon capital.